The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Observational study of the extent of lymph node metastasis among patients who underwent pancreatoduodenectomy for non-ampullary duodenal cancer using the National Clinical Database in Japan.
 
Yasuhiro Kodera
Stock and Other Ownership Interests - Abbvie
Honoraria - Bristol Myers Squibb; Chugai Pharma; Daiichi Sankyo; Edwards Lifesciences; Lilly Japan; Miyarisan Pharmaceutical; MSD K.K; Ono Pharmaceutical; Taiho Pharmaceutical; Taisho Pharmaceutical Holdings; Yakult Honsha
Consulting or Advisory Role - Daii Sankyo
Research Funding - abbott Japan (Inst); Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); EA Pharma (Inst); Kaken Pharmaceutical (Inst); Lilly Japan (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Nippon Kayaku (Inst); Otsuka (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Masamichi Hayashi
No Relationships to Disclose
 
Hiroyuki Yamamoto
Research Funding - General Incorporated Association National Clinical Database (Inst); Intuitive Surgical Sarl (Inst); Johnson & Johnson (Inst); Nipro Corporation (Inst)
 
Keisuke Kurimoto
No Relationships to Disclose
 
Haruyoshi Tanaka
No Relationships to Disclose
 
Hideki Takami
No Relationships to Disclose
 
Yoshihiro Kakeji
Honoraria - Bristol Myers Squibb; Chugai Pharma; Covidien; DAIICHI SANKYO COMPANY, LIMITED; Johnson & Johnson; Lilly; Merck; Merck Sharp and Dohme; Miyarisan pharmaceutical; Nippon Kayaku; Olympus Marketing, Inc.; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Tsumura & Co.; Yakult Honsha
Research Funding - Taiho Pharmaceutical (Inst)